The American healthcare system is a hot topic for debate, especially given the significant disparities in cost and quality compared to other developed nations. Many often ask: will it ever get better?
Navigating the complexity of healthcare systems can be a daunting experience for patients, often bringing to light the quintessential question: What do patients truly desire regarding their healthcare? A seamless experience, high-quality care, compassionate treatment, and easy accessibility undoubtedly top the list.
Ensuring patient satisfaction is not just a matter of good practice; it’s essential for delivering high-quality care and building trust between patients and healthcare providers. Satisfied patients are more likely to adhere to treatment plans, return for follow-up care, and recommend their healthcare providers to others.
Technological advances, patient expectations, and evolving regulatory frameworks profoundly transform the healthcare landscape. For pharma companies, this rapidly changing environment presents both challenges and opportunities. To thrive in the future of healthcare, pharma companies must adapt and innovate.
More than 70% of U.S. adults feel the healthcare system is failing to meet their needs in at least one way, according to new data from the Harris Poll. Only 27% of the survey participants said the U.S. medical system meets all their needs.
The American healthcare industry is facing unparalleled challenges. An aging population, physician burnout, and lack of trust in government healthcare agencies are part of a huge problem that can’t be solved with bigger budgets.
The United States has dramatically higher healthcare prices than other advanced economies. This is the case for surgical procedures, diagnostic tests, prescription drugs, and almost any other type of healthcare service. Administrative healthcare costs are higher as a share of GDP in the United States than in other countries. These administrative (i.e., nonclinical) costs take several forms: claims processing and payment, prior authorization and eligibility determinations, and quality measurement, among others.